APA (7th ed.) Citation

Y, X., JP, W., C, K., B, S., C, W., M, D., . . . AW, L. (2026). Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitis. Journal of hepatology, 85(1), 71. https://doi.org/10.1016/j.jhep.2026.02.026

Chicago Style (17th ed.) Citation

Y, Xu, et al. "Integrative Omics and Phase IIa Clinical Trial Identify TNF as Key Node in Autoimmune Hepatitis." Journal of Hepatology 85, no. 1 (2026): 71. https://doi.org/10.1016/j.jhep.2026.02.026.

MLA (9th ed.) Citation

Y, Xu, et al. "Integrative Omics and Phase IIa Clinical Trial Identify TNF as Key Node in Autoimmune Hepatitis." Journal of Hepatology, vol. 85, no. 1, 2026, p. 71, https://doi.org/10.1016/j.jhep.2026.02.026.